Abstract:Key PointsTwo major classes of ubiquitin ligases, the SKP1–CUL1–F-box-protein (SCF) complex and the anaphase-promoting complex/cyclosome (APC/C), have a central role in cell-cycle regulation.The SCF complex and APC/C are structurally similar. Each is constituted of common subunits and a variable substrate-recognition subunit (F-box proteins for the SCF complex and activators for the APC/C). Three F-box proteins in the SCF complex — S-phase kinase-associated protein 2 (SKP2), F-box and WD-40 domain protein 7 (FBW7) and β-transducin repeat-containing protein (β-TRCP) — and two activators in the APC/C — cell division cycle 20 (CDC20) and CDH1 (also known as HCT1) — are the most important in cell-cycle regulation.SKP2 targets negative regulators of the cell cycle such as p27, p21 and p57 for degradation, and thereby promotes cell-cycle progression during S and G2 phases. SKP2 is upregulated in many human cancers.FBW7 induces the degradation of positive regulators of the cell cycle, such as MYC, JUN, cyclin E and Notch. FBW7 is often mutated in a subset of human cancers.β-TRCP is a versatile F-box protein that recognizes several cell-cycle regulators — EMI1/2, WEE1A and CDC25A/B — in addition to its classical substrates, β-catenin and IκB. In some cancers, β-TRCP mutation or overexpression is found.CDC20 targets securin and mitotic cyclins for destruction, and thereby promotes sister-chromatid separation. CDC20 is the crucial mediator of the spindle checkpoint, which prevents aneuploidy and genomic instability. CDC20 is overexpressed in some cancers, although in others the CDC20 gene is mutated or deleted.CDH1 facilitates exit from M phase and maintains G1 phase by mediating the degradation of mitotic cyclins, non-CDK (cyclin-dependent kinase) mitotic kinases and some regulators of the formation of pre-replicative complexes. Deregulated expression or mutation of CDH1 as well as of most CDH1 targets have been described in human cancers.

Cullin1 and malignant tumors

The Functions and Properties of Cullin-5, a Potential Therapeutic Target for Cancers.

Overexpression of Cullin1 is associated with poor prognosis of patients with gastric cancer.

Cull Expression Is Increased In Early Stages Of Human Melanoma

Cullin Family Proteins and Tumorigenesis: Genetic Association and Molecular Mechanisms

Increased Cul1 Expression Promotes Melanoma Cell Proliferation Through Regulating P27 Expression

High expression of Cullin1 indicates poor prognosis for NSCLC patients.

Cullin 4-DCAF Proteins in Tumorigenesis

Cullin1 is a Novel Prognostic Marker and Regulates the Cell Proliferation and Metastasis in Colorectal Cancer

Cullin-RING ligases in regulation of autophagy

Cullin-1 Promotes Cell Proliferation Via Cell Cycle Regulation and is a Novel in Prostate Cancer

Cullin-1 Promotes Cell Proliferation in Human Breast Cancer and is Related to Diabetes

The functional analysis of Cullin 7 E3 ubiquitin ligases in cancer

Cullin 3 Targets Methionine Adenosyltransferase Ii Alpha for Ubiquitylation-Mediated Degradation and Regulates Colorectal Cancer Cell Proliferation

Cullin-Ring Ligase 5: Functional Characterization And Its Role In Human Cancers

The Expression of Cullin1 is Increased in Renal Cell Carcinoma and Promotes Cancer Cell Proliferation, Migration, and Invasion

Cullin-RING Ligase 5: Functional Characterization and Its Role in Human Cancers.

Ubiquitin ligases: cell-cycle control and cancer

CUL3 (cullin 3)-mediated ubiquitination and degradation of BECN1 (beclin 1) inhibit autophagy and promote tumor progression

Functional analysis of Cullin 3 E3 ligases in tumorigenesis

Pathogenic Roles of the Cullin E3 Ligase Scaffolding Protein CUL4B